Ms Lara Kristin Dunn, MA CCC-SLP | |
1111 Sherman Ave, Hood River, OR 97031-1421 | |
(541) 380-0752 | |
Not Available |
Full Name | Ms Lara Kristin Dunn |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 1111 Sherman Ave, Hood River, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1831358225 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 11832 (Oregon) | Primary |
235Z00000X | Speech-language Pathologist | LL00003725 (Washington) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Ms Lara Kristin Dunn, MA CCC-SLP 1111 Sherman Ave, Hood River, OR 97031-1421 Ph: (541) 380-0752 | Ms Lara Kristin Dunn, MA CCC-SLP 1111 Sherman Ave, Hood River, OR 97031-1421 Ph: (541) 380-0752 |
News Archive
A new piece of research led by the University of Southampton has found that the behaviour of fruit flies, which are commonly used in laboratory experiments, is altered by electric fields.
The AGA Research Foundation is honored to announce the first AGA-Caroline Craig Augustyn and Damian Augustyn Award in Digestive Cancer, which will support Andrew D. Rhim, MD, from the Perelman School of Medicine at the University of Pennsylvania, Philadelphia, as he furthers his research on the role of Zeb1 in pancreas development, regeneration and cancer progression.
A study published online on May 24th in the Journal of Experimental Medicine (www.jem.org) suggests that boosting the abundance of one of the body's own proteins might be more effective than antibiotic treatment at fighting off a common meningitis-causing bacterium (E. coli K1).
Lux Biosciences, Inc., a privately held biotechnology company focused on the development and commercialization of therapies for serious ophthalmic diseases, today announced that the company has closed a $50 million Series B venture financing. Participants in the funding were current investors in Lux Biosciences, HBM Bioventures, Novo A/S, Prospect Venture Partners and SV Life Sciences (SVLS), as well as SVLS' publicly traded fund, International Biotechnology Trust plc.
› Verified 2 days ago
Ms. Eliza Louise Heavenrich, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 805 State St Apt 2, Hood River, OR 97031 Phone: 503-298-1009 | |
Megan Marie Burfield, M.S., CFY-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 Oak St Ste 200, Hood River, OR 97031 Phone: 541-386-0009 Fax: 541-386-0029 | |
Juliana Stevens Cuyler, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1015 Hutson Rd, Hood River, OR 97031 Phone: 541-806-9193 | |
Rebecca Michelle Tunell, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 315 Oak St Ste 200, Hood River, OR 97031 Phone: 541-386-0009 | |
Jenna Lynette Bartley, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1706 Avalon Dr Unit 23, Hood River, OR 97031 Phone: 541-645-0582 | |
Nicole Kvist, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1700 12th St Ste C, Hood River, OR 97031 Phone: 541-716-1316 | |
Kimberley Ann Ellis, MA/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1627 Woods Ct, Hood River, OR 97031 Phone: 541-387-1949 |